Medical Articles 3/27

Posted by rob on March 27, 2007 under Uncategorized | Be the First to Comment

[Haemolytic
uremic syndrome and acute mesenteric ischemia caused by
interferon-alpha-2b in the treatment of Kaposi's sarcoma in an AIDS
patient.]

Evaluation of the Cepheid GeneXpert BCR-ABL Assay.
Synergistic
interactions between 12-0-tetradecanoylphorbol-13-acetate (TPA) and
imatinib in patients with chronic myeloid leukemia in blastic phase
that is resistant to standard-dose imatinib.
Allogeneic
hematopoietic stem cell transplantation for the treatment of high-risk
acute myelogenous leukemia and myelodysplastic syndrome using
reduced-intensity conditioning with fludarabine and melphalan.
Allogeneic
hematopoietic progenitor cell transplantation for the treatment of
chronic myelogenous leukemia in the era of tyrosine kinase inhibitors:
lessons learned to date.
Immunotherapy in chronic myelogenous leukemia.
Management of patients with newly diagnosed chronic myeloid leukemia: opportunities and challenges.
A
case report of therapeutic leukapheresis in an adult with chronic
myelogenous leukemia presenting with hyperleukocytosis and leukostasis.

An analysis of current neutropenia therapies, including pegfilgrastim.

Medical Articles 3/22

Posted by rob on March 23, 2007 under Uncategorized | Be the First to Comment

Impact
of cytogenetics on outcome of matched unrelated donor hematopoietic
stem cell transplantation for acute myeloid leukemia in first or second
complete remission.

Disseminated
xanthogranulomas associated with adult T-cell leukaemia/lymphoma: a
case report and review the association of haematologic malignancies.
Iowa radon leukaemia study: a hierarchical population risk model for spatially correlated exposure measured with error.
Evaluation of the l-stereoisomeric nucleoside analog troxacitabine for the treatment of acute myeloid leukemia.
Acute myelogenous leukemia as the cause of a nonhealing infection in a 10-month-old infant.
Philadelphia
chromosome-positive acute myeloid leukemia: a rare aggressive leukemia
with clinicopathologic features distinct from chronic myeloid leukemia
in myeloid blast crisis.

Risk factors for acute leukemia in children: a review.

Medical Articles 3/17

Posted by rob on March 17, 2007 under Uncategorized | Be the First to Comment

Evidence of population mixing based on the geographical distribution of childhood leukemia in Ohio.

Timed-sequential chemotherapy as induction and/or consolidation regimen for younger adults with acute myelogenous leukemia.
Targeting
autophagy augments the anticancer activity of the histone deacetylase
inhibitor SAHA to overcome Bcr- Abl-mediated drug resistance.
Dok-3 plays a non-redundant role in negative regulation of B cell activation.
Histone H2AX Is a Mediator of Gastrointestinal Stromal Tumor Cell Apoptosis following Treatment with Imatinib Mesylate.
From mRNA metabolism to cancer therapy: chronic myelogenous leukemia shows the way.
Resistance to c-KIT kinase inhibitors conferred by V654A mutation.
Apaf1
in Chronic Myelogenous Leukemia (CML) Progression: Reduced Apaf1
Expression is Correlated with a H179R p53 Mutation During Clinical
Blast Crisis.

Multiplex
reverse transcription-polymerase chain reaction for simultaneous
screening of 29 chromosomal translocation in hematologic malignancies.

Medical Articles 3/14

Posted by rob on March 14, 2007 under Uncategorized | Be the First to Comment

Blastoid mantle cell lymphoma occurring in a patient in complete remission of chronic myelogenous leukemia.

QT prolongation and Torsades de Pointes in patients previously treated with Anthracyclines.
Follow-up Study of Patients Diagnosed with Chronic Myelogenous Leukemia Treated with STI 571 in Ecuador.
Aberration of 3q and monosomy 7 in a child with acute myelogenous leukemia.
An inv(16) in Ph-negative cells of a chronic myelogenous leukemia patient after imatinib treatment.
Role
of BCR/ABL gene expression levels in determining the phenotype and
imatinib sensitivity of transformed human hematopoietic cells.

Aberrant DNA methylation of the Src kinase Hck, but not of Lyn, in Philadelphia chromosome negative acute lymphocytic leukemia.

Medical Articles 3/8

Posted by rob on March 8, 2007 under Uncategorized | Be the First to Comment

Outcome of patients with Philadelphia chromosome-positive chronic myelogenous leukemia post-imatinib mesylate failure.
Subclassification
of patients with acute myelogenous leukemia based on chemokine
responsiveness and constitutive chemokine release by their leukemic
cells.
The chronic myeloproliferative disorders and mutation of JAK2: Dameshek’s 54 year old speculation comes of age.

Medical Articles 3/3

Posted by rob on March 3, 2007 under Uncategorized | Be the First to Comment

The folate receptor: What does it promise in tissue-targeted therapeutics?
Identification
of candidate molecular markers predicting sensitivity in solid tumors
to dasatinib: rationale for patient selection.
RIL, a LIM Gene on 5q31, Is Silenced by Methylation in Cancer and Sensitizes Cancer Cells to Apoptosis.
A
Phase 1 Study of the Proteasome Inhibitor Bortezomib in Pediatric
Patients with Refractory Leukemia: a Children’s Oncology Group Study.
The anticancer drug imatinib induces cellular autophagy.

Medical Articles 3/1

Posted by rob on March 1, 2007 under Uncategorized | Be the First to Comment

Sunitinib: from rational design to clinical efficacy.
Chaperone-rich
cell lysate embedded with BCR-ABL peptide demonstrates enhanced
anti-tumor activity against a murine BCR-ABL positive leukemia.
An updated study of mortality among North American synthetic rubber industry workers.
home top